Skip to content

A study to compare the efficacy of two different procedural treatments of patchy hair loss.

RANDOMIZED CONTROL STUDY OF PLATELET RICH PLASMA VERSUS INTRALESIONAL TRIAMCINOLONE ACETONIDE IN MODERATE TO SEVERE ALOPECIA AREATA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012046
Enrollment
75
Registered
2018-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ALOPECIA AREATA

Interventions

Intervention1: Autologous Platelet Rich Plasma Therapy: patients will be injected intradermally 0.1ml/cm2 autologous PRP into the lesional area over the scalp by insulin syringe once in 4 weeks, for

Sponsors

MAHARAJAHS INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of alopecia areata in people more than 18 years old. 2. Moderate to severe AA with SALT score more than 25. 3.Not on treatment in the past 3 months for AA.

Exclusion criteria

Exclusion criteria: 1. Patients with H/o bleeding disorders 2. Patients who are on anti coagulant medication 3. Patients who had keloidal tendency 4. Patients with Thrombocytopenia 5. Patients suffering from HIV and other infectious diseases.

Design outcomes

Primary

MeasureTime frame
measures will be the improvement in SALT,BURNING ITCHING SCORE after 16 weeks (4th sitting) of treatment.Timepoint: 16 weeks after 1st sitting of treatment.

Secondary

MeasureTime frame
measures will be maintenance of improvement in SALT ,BURNING ITCHING SCORE Six months after the 4th sitting of treatmentTimepoint: 6 months after 4th sitting(16 weeks ofter 1st sitting) of treatment

Countries

India

Contacts

Public ContactMarikanti Jayakumar

Maharajahs Institute of Medical Sciences

kvtgopal77@gmail.com9440156552

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026